ACE Inhibitors

Type: Keyphrase
Name: ACE Inhibitors
First reported 11 hours ago - Updated 9 hours ago - 1 reports

Global Hypertension Drugs Market 2014-2018 with Actelion, AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Sanofi Dominating

Research and Markets (http://www.researchandmarkets.com/research/brq49m/global) has announced the addition of the "Global Hypertension Drugs Market 2014-2018" report to their offering. The Global Hypertension Drugs market is driven by several factors, ... [Published Individual.com - 11 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Major sign of kidney and heart damage often ignored: proteinuria

Ratings require JavaScript to be enabled.Many patients with too much protein in their urine - the earliest sign of kidney damage and a risk factor for heart disease - go untreated, according to new findings presented at the National Kidney Foundation's ... [Published Medical News Today - 16 hours ago]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Early Sign of Kidney Disease Often Ignored, Study Says

(HealthDay News) -- Too much protein in your urine -- an early sign of kidney disease and a risk factor for heart disease -- often goes undetected and untreated, a new study finds.Researchers also found that many people with this problem, called proteinuria, ... [Published Health Finder - Apr 23 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

Proving Obvious with Post-Filing Evidence?: Yes

Sanofi-Aventis v. Glenmark ( Fed. Cir. 2014 ) In a post on the Patent Ethics site, Professor Hricik highlights this case with the following headline: CAFC Affirms Adverse Inference Instruction Due to Spoliation . Post Filing Recognition of Synergy ... [Published Patent Law Blog (Patently-O) - Apr 21 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

We Need a New Earth Day

The first Earth Day, in 1970, was celebrated after a wave of environmentalism swept the nation. Many give credit to Rachel Carson’s 1962 book, Silent Spring , which popularized the notion of large-scale chemical pollution, for igniting the movement.But ... [Published Cato Institute - Apr 22 2014]
First reported Apr 20 2014 - Updated Apr 20 2014 - 1 reports

European Medicines Agency recommends against combining RAS-acting drugs

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has issued a recommendation against the combined use of different classes of medications acting on the renin-angiotensin system.The drug classes mentioned in the recommendation ... [Published Orthopedics Today - Apr 20 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Big Pharma: What have you done for me lately?

A drug has been developed that is a true miracle of modern pharmacology. I say this because it can reduce deaths for patients with congestive heart failure (CHF) as much as a $10,000 defibrillator.It is perhaps the most effective drug we have to help ... [Published Ridgefield Press - Apr 19 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Letter from the Editor #725

This past week I was in the corporate office of one of the most successful ACO's in the country meeting with members of their diabetes initiative project. As you know, improvement in A1c's is a major grading point for 5-star quality ratings and this group ... [Published Diabetes in Control - Apr 19 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Benefits of ARBs Not the Same as ACE Inhibitors

AdvertisementAngiotensin-converting enzyme inhibitors (ACEIs) are a mainstay class of antihypertensive medications with proven benefits in not only hypertensive patients but also in conditions such as diabetes. Some patients taking ACEIs may experience ... [Published Diabetes in Control - Apr 19 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 2 reports

ACE inhibitors cut diabetes deaths

Angiotensin-converting enzyme inhibitors (ACEIs) reduce deaths and major cardiovascular events in patients with diabetes mellitus whereas angiotensin II receptor blockers (ARBs) lack these benefits, a meta-analysis has found.The pooled analysis of 35 ... [Published Pharmacy Magazine - Apr 08 2014]
First reported Apr 01 2014 - Updated Apr 02 2014 - 3 reports

Analysts, experts are dazzled by the blockbuster potential of Novartis' LCZ696

The data aren't out yet, but the buzz about Novartis' new late-stage contender for blockbuster status is growing to fever pitch. This morning Leerink opted to add on $3 billion to the pharma giant's forecasted revenue for 2026, concluding that LCZ696 ... [Published FierceBiotech - Apr 02 2014]
First reported Mar 30 2014 - Updated Mar 31 2014 - 2 reports

Efforts to curb hospital readmissions take center stage

PUBLIC RELEASE DATE: 29-Mar-2014WASHINGTON (March 29, 2014) — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified in six new ... [Published EurekAlert! - Mar 31 2014]

Quotes

There have been other studies in this field of life extension by researching various supplements. Also see the study, " Effect of Carnosine and Its Trolox-Modified Derivatives on Life Span of Drosphila melanogaster ." In that study, however, the supplements mentioned in that research experiment increased the lifespan of male insects by 16% and also increased the lifespan...

More Content

All (140) | News (129) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
What are the differences between carnosine and ... [Published Examiner.com - 4 hours ago]
Hamilton-based Medical Hero Inducted into The C... [Published Canada NewsWire - 8 hours ago]
Global Hypertension Drugs Market 2014-2018 with... [Published Individual.com - 11 hours ago]
Major sign of kidney and heart damage often ign... [Published Medical News Today - 16 hours ago]
This Is What Happens To Your Body When You Quit... [Published Medical Daily - Apr 23 2014]
Early Sign of Kidney Disease Often Ignored, Stu... [Published Health Finder - Apr 23 2014]
Seniors face risks in today's drug culture [Published BlueRidgeNow.com - Apr 23 2014]
Focus on Heart Health [Published Agency for Healthcare Research and Quality - Apr 23 2014]
One Step Forward on Quality Improvement, One St... [Published Agency for Healthcare Research and Quality - Apr 23 2014]
Comparing Blood Pressure Medicines [Published Agency for Healthcare Research and Quality - Apr 23 2014]
Use of SFRP-3 in the assessment of heart failure [Published PharmCast - Apr 23 2014]
We Need a New Earth Day [Published Cato Institute - Apr 22 2014]
U.S. Cardiologists Indicate Ivabradine May Beco... [Published Diagnostic & Invasive Cardiology - Apr 22 2014]
Proving Obvious with Post-Filing Evidence?: Yes [Published Patent Law Blog (Patently-O) - Apr 21 2014]
NOXXON announces encouraging data from Phase II... [Published Individual.com - Apr 21 2014]
European Medicines Agency recommends against co... [Published Orthopedics Today - Apr 20 2014]
Big Pharma: What have you done for me lately? [Published Ridgefield Press - Apr 19 2014]
Letter from the Editor #725 [Published Diabetes in Control - Apr 19 2014]
Benefits of ARBs Not the Same as ACE Inhibitors [Published Diabetes in Control - Apr 19 2014]
The SYMPLICITY HTN-3 Co-PI Gives His 2 Cents [Published General Medicine eJournal - Apr 18 2014]
U.S. Cardiologists Indicate that Servier's Ivab... [Published Individual.com - Apr 17 2014]
Findings from University of Copenhagen Reveals ... [Published HispanicBusiness.com - Apr 17 2014]
Patent Issued for Use of SFRP-3 in the Assessme... [Published 4 Traders - Apr 17 2014]
High blood pressure? Eat Norwegian cheese, says... [Published Dairy Reporter - Apr 16 2014]
4 Foods That Have Surprising Medicinal Benefits [Published Mark's Daily Apple - Apr 16 2014]
Does Pfizer Offer Good Value? [Published Motley Fool Discussion Boards - Apr 15 2014]
Atlanta Medical Center Recognized for Outstandi... [Published East Atlanta Patch - Apr 15 2014]
Survey: Ivabradine Set to Become ‘Gold Standard... [Published P&T Community - Apr 15 2014]
European review prompts warning against “dual b... [Published PJ Online - Apr 15 2014]
Global Hypertension Drugs Market 2014-2018 [Published MarketResearch.com - Apr 15 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Proving Obvious with Post-Filing Evidence?: Yes [Published Patent Law Blog (Patently-O) - Apr 21 2014]
Sanofi-Aventis v. Glenmark ( Fed. Cir. 2014 ) In a post on the Patent Ethics site, Professor Hricik highlights this case with the following headline: CAFC Affirms Adverse Inference Instruction Due to Spoliation . Post Filing Recognition of Synergy ...
4 Foods That Have Surprising Medicinal Benefits [Published Mark's Daily Apple - Apr 16 2014]
“Let food be thy medicine,” said some old Roman guy, I think. Whoever he was, he was right. Food is the foundation for preventive medicine. It’s the first thing we examine when figuring out a health issue, and successful changes to what we eat usually ...
Will We Ever Accept that Exercise is Often the ... [Published Mark's Daily Apple - Apr 03 2014]
For years, experts have known that in mild to moderate cases of depression exercise is as effective (or more effective) a treatment as prescription drugs. Yet, here we are in 2014, with still climbing obesity rates and higher than ever numbers of ...
Tekturna Should Not Be Used In Combination With... [Published Drug Injury Watch - Mar 25 2014]
In Addition, Such Combined Use In Patients With Kidney Disease Or Diabetes Increases Risks Of Having A Stroke As Well As Fainting And Falling (Posted by Tom Lamb at DrugInjuryWatch.com ) In February 2014 Health Canada issued new safety information ...
Essential Thrombocythaemia... A few questions... [Published HealthBoards - Mar 06 2014]
Hi,I have just found out I have tested positive for Jak2. This is after a number of years of blood tests showing I had raised platelets and ignored or dismissed as part of my general makeup. My levels were never terribly raised - into the 500s and recently ...
1 2

Press Releases

sort by: Date | Relevance
Takeda and Arbor Announce a Licensing Agreement... [Published PR Newswire - Sep 12 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.